Apnimed (APMD) vs Obsidian Therapeutics (OBX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Apnimed is the larger company by market cap ($758.5 million vs $756.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APMD | OBX |
|---|---|---|
| Share price | $18.22 | $12.24 |
| Market cap | $758.51M | $756.10M |
| 1-day change | +1.00% | -7.27% |
| P/E ratio (TTM) | 2.51 | — |
| EPS (TTM) | $7.27 | $-1.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $35.29 | $49.97 |
| 52-week low | $16.12 | $12.07 |
| Distance from 52-week high | -48.37% | -75.51% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +176.23% | +218.63% |
| Average volume | 552.07K | 367.35K |
| Shares outstanding | 41.63M | 61.77M |
| Employees | 81 | 87 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Apnimed
APMD stock →Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets.
Health Care · Biotechnology: Pharmaceutical Preparations · 81 employees
About Obsidian Therapeutics
OBX stock →Obsidian Therapeutics, Inc. operates as a clinical-stage biotechnology company developing engineered cell and gene therapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees
APMD vs OBX FAQ
Which is bigger, Apnimed or Obsidian Therapeutics?
Apnimed (APMD) is larger, with a market capitalization of $758.51M compared with $756.10M for Obsidian Therapeutics (OBX).
Are Apnimed and Obsidian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.